Gong Y - Search Results

1

The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.

Yang J, Zhao L, Wu Y, Niu T, Gong Y, Chen X, Huang X, Liu J, Dai Y, Ma H. Yang J, et al. Among authors: gong y. Cancer Med. 2023 Dec;12(23):21111-21117. doi: 10.1002/cam4.6669. Epub 2023 Nov 8. Cancer Med. 2023. PMID: 37937729 Free PMC article.

2

[Studies on the predictors of response to immunosuppressive therapy in severe aplastic anemia patients].

Mu XY, Chang H, Liu T, Gong YP, Niu T, Qin H, Ma HB, Meng WT. Mu XY, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 Sep;40(5):897-900. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19950609 Chinese.

3

Antileukaemia effect of rapamycin alone or in combination with daunorubicin on Ph+ acute lymphoblastic leukaemia cell line.

Yang X, Lin J, Gong Y, Ma H, Shuai X, Zhou R, Guo Y, Shan Q, He G. Yang X, et al. Among authors: gong y. Hematol Oncol. 2012 Sep;30(3):123-30. doi: 10.1002/hon.1013. Epub 2011 Sep 4. Hematol Oncol. 2012. PMID: 21898527

4

Nutlin-3 plus tanshinone IIA exhibits synergetic anti-leukemia effect with imatinib by reactivating p53 and inhibiting the AKT/mTOR pathway in Ph+ ALL.

Guo Y, Li Y, Xiang B, Huang XO, Ma HB, Wang FF, Gong YP. Guo Y, et al. Among authors: gong yp. Biochem J. 2017 Dec 6;474(24):4153-4170. doi: 10.1042/BCJ20170386. Biochem J. 2017. PMID: 29046392

5

The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway.

Guo Y, Li Y, Wang FF, Xiang B, Huang XO, Ma HB, Gong YP. Guo Y, et al. Among authors: gong yp. Int J Biochem Cell Biol. 2019 Jan;106:8-20. doi: 10.1016/j.biocel.2018.10.008. Epub 2018 Oct 30. Int J Biochem Cell Biol. 2019. PMID: 30389549

6

Adoptive cell therapy for acute myeloid leukemia.

Ma H, Padmanabhan Iyer S, Parmar S, Gong Y. Ma H, et al. Among authors: gong y. Leuk Lymphoma. 2019 Jun;60(6):1370-1380. doi: 10.1080/10428194.2018.1553300. Epub 2019 Jan 10. Leuk Lymphoma. 2019. PMID: 30628504 Review.

7

Targeting CLL-1 for acute myeloid leukemia therapy.

Ma H, Padmanabhan IS, Parmar S, Gong Y. Ma H, et al. Among authors: gong y. J Hematol Oncol. 2019 Apr 24;12(1):41. doi: 10.1186/s13045-019-0726-5. J Hematol Oncol. 2019. PMID: 31014360 Free PMC article. Review.

8

Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis.

Wu X, Wang H, Deng J, Zheng X, Ling Y, Gong Y. Wu X, et al. Among authors: gong y. Ann Hematol. 2019 Nov;98(11):2485-2496. doi: 10.1007/s00277-019-03774-z. Epub 2019 Sep 3. Ann Hematol. 2019. PMID: 31482295

9

[Relationship of Cystic Fibrosis Transmembrane Conductance Regulator Expression with Clinical Features and Prognosis in Patients with Acute Leukemia].

Wang HF, Yang X, Liu XH, Naren DL, Sang LN, Yan TY, Zheng X, Li YR, Zhang NC, Gong YP. Wang HF, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019 May;50(3):420-424. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 31631611 Chinese.

10

High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m⁶A methylation of MYC mRNA.

Naren D, Yan T, Gong Y, Huang J, Zhang D, Sang L, Zheng X, Li Y. Naren D, et al. Among authors: gong y. J Cancer Res Clin Oncol. 2021 Jan;147(1):33-47. doi: 10.1007/s00432-020-03373-w. Epub 2020 Sep 3. J Cancer Res Clin Oncol. 2021. PMID: 32880751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,267 results

Search Page

Filters